Return to homepagePandemic Pact

COVID-HP

  • Funded by Partnership for Advanced Computng in Europe (PRACE)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Partnership for Advanced Computng in Europe (PRACE)

  • Principal Investigator

    Jean-Philip Piquemal

  • Research Location

    France, United States of America

  • Lead Research Institution

    Sorbonne Université

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-HP is led by Prof. Jean-Philip Piquemal from Sorbonne University in France together with complementary teams from leading universities and institutes in France and the USA. In the coming six months scientists will conduct biomolecular research to understand the mechanisms of the virus infection and bio-simulations to develop therapeutics. The consortium has prepared different traps for the virus: they aim to find inhibitors capable of selectively targeting some of the key proteins, as well as key nucleic acid sequences in its genome. All these complex studies and simulations require high computational power and PRACE awarded the consortium 20 000 000 core hours on Joliot-Curie Rome, hosted by GENCI at CEA, France.